Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
cureTV – Empowering Patients Through Video
Colorectal Cancer Makeup May Differ by Age Group
Aaron Franke, M.D.
Recent research found that patients under 50 were less likely to have a treatment-determining biomarker than their older counterparts.
Comparing Two MPN Drugs
Trine Alma Knudsen, M.D.
An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).
When Facing Metastatic Prostate Cancer, Know What to Ask Your Doctor
There are some key discussions that men with metastatic prostate cancer should have with their health care providers.
Participating in a Lung Cancer Registry Can Be Empowering
Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.
Don't Write Off Immunotherapy in Brain Cancer Just Yet
David Reardon, M.D.
Researchers should not give up hope in using immunotherapy to treat brain cancers.
Building Resiliency in the World of Oncology
Thomas A. Gallo, MS, MDA
As the number of patients and survivors continues to increase, it is important that clinician burnout is handled appropriately, explains Thomas A. Gallo.
Advocacy Groups Collaborate in the Fight Against Prostate Cancer
It is important that advocacy organizations unify their message, says Mike Crosby, the founder of the Veterans Prostate Cancer Awareness group.
PD-L1: An Important, But Imperfect Biomarker
H. Jack West, M.D.
Some immunotherapy drugs target the PD-L1 protein, though this expert says that it is still an imperfect biomarker.
Patients With CRC: Advocate to Have Your Tumor Tested
By getting their tumor genetically tested, a patient may find out that they are eligible for certain treatment options.
Focusing on Improving Depression in HNC Survivors
Nosayaba Osazuwa-Peters, BDS, MPH, CHES
As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
What is your status?
Out of Treatment